H.C. Wainwright maintains $100 target, Buy on Immunocore stock
In conclusion, H.C. Wainwright's analyst remains optimistic about Immunocore's prospects, underpinned by the potential of its diverse pipeline and upcoming clinical milestones. With a market ...
What a US exit from the WHO means for global health
For decades, the United States has held considerable power in determining the direction of global health policies and ...
AIDS relief funding faces disruption after foreign aid pause ordered: Report
Secretary of State Marco Rubio’s foreign aid pause threatens PEPFAR, risking delays in life-saving HIV treatments for 20 ...